Exploring Medicare Provider Networks: Implications for Adoption of CER Findings
探索医疗保险提供者网络:采用 CER 研究结果的影响
基本信息
- 批准号:8332819
- 负责人:
- 金额:$ 19.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAffectAreaCardiacCaringCharacteristicsChronicChronic CareClinicalCoronaryDataDiabetes MellitusEvidence based practiceExpenditureFutureGeographic LocationsGeographyGoalsGrowthHealthHealth ExpendituresHealthcareLong-Term CareMedicalMedicareMedicare claimMinorityMyocardial IschemiaOutcomeOutcomes ResearchPatientsPatterns of CarePhysiciansPoliciesPopulationProceduresProviderPublicationsPublishingResearchSavingsSeminalSocial NetworkSpecialistStentsStructureSurgeonTestingTimeVariantWomanWorkabstractingbaseclinical practicecohortcomparative effectivenesscostcost effectivedesigneffectiveness researchevidence baseimprovedpaymentresponsevirtual
项目摘要
Abstract
If comparative effectiveness research (CER) is to reduce health expenditure growth without compromising
health outcomes, providers will need to adopt long-term cost-saving strategies that are identified as being no
less effective than higher-cost clinical strategies. Understanding how provider "virtual" networks for Medicare
influence the cost and content of care may be important when considering health reforms designed to promote
the use of lower-cost effective medical care.
We propose identifying factors that determine or influence the use of cost-saving yet effective clinical
strategies. We further propose investigating the influence of Medicare provider networks (virtual or social
networks) and their structure on the cost and content (e.g., evidence-based practices or not) of care provided.
Our specific aims are to: 1) determine the extent to which supply and demand factors predict provider adoption
of cost-saving evidence-based findings, 2) analyze provider network structure for differences in and influence
on the use of evidence-based practices and costs of care, 3) estimate potential Medicare expenditure savings
based on policies implementing these findings (perhaps through the use of payment or health reforms such as
bundled payments or ACOs).
We will base our analysis on the complete Medicare claims files for Parts A and B from years 2005 to 2010
and Part D from 2006 to 2010. Specifically, we will apply these aims to the treatment of patients with chronic
stable angina and the use of revascularization with coronary stents before and after evidence-based findings
(the COURAGE trial in 2007) were published supporting the initial use of medical management. We will
identify the relevant cohort from the Medicare claims files for the time period before and after the time of
publication, and identify factors that predicted a change in provider practices from revascularization with stents
to medical management in the data. We will control for demographic and patient-level characteristics,
investigate ecological and supply determinants, and investigate differences across geographies and patient
sub-populations such as women, minorities, and those with diabetes. Next, we will identify provider networks
of care for chronic stable angina in the Medicare data, and explore whether provider network structure
influences the cost or content of care provided (concordant with evidence-based practices or not). We will
explore whether network structures differ across geographies, and whether this partially explains the difference
in practice variation and cost between regions. We will identify ways that our findings might be integrated into
health reform policies either to optimize the factors we identify as determinants of low-cost yet effective care or
to encourage efficient provider network formation. Finally, we will estimate potential Medicare savings based
upon these policies.
抽象的
如果比较有效性研究(CER)是为了减少健康支出的增长而不损害
健康成果,提供者将需要采用长期省成本的策略,这些策略被确定为没有
不如更高成本的临床策略有效。了解医疗保险的提供商如何“虚拟”网络
在考虑旨在促进的健康改革时,影响护理的成本和内容可能很重要
使用低成本的有效医疗服务。
我们建议识别确定或影响使用省略成本但有效临床使用的因素
策略。我们进一步建议调查Medicare提供商网络(虚拟或社会网络的影响)
网络)及其在提供的护理成本和内容(例如,是否基于证据的实践)上的结构。
我们的具体目的是:1)确定供求因素预测提供者采用的程度
基于循证的循证发现,2)分析提供商网络结构的差异和影响
关于使用循证实践和护理成本,3)估计潜在的Medicare支出节省
根据实施这些发现的政策(也许是通过使用付款或健康改革,例如
捆绑付款或ACO)。
我们将根据2005年至2010年的A和B部分的完整Medicare索赔文件进行分析
并从2006年到2010年的D部分。具体来说,我们将将这些目标应用于慢性患者的治疗
稳定的心绞痛以及在基于证据的发现之前和之后使用冠状动脉支架的血运重建
(2007年的勇气审判)发表了支持医疗管理的初始使用。我们将
从Medicare索赔文件中确定相关队列的文件
出版,并确定预测提供者实践变化的因素,从具有支架的血运重建
到数据中的医疗管理。我们将控制人口统计和患者级特征,
调查生态和供应决定因素,并调查地理和患者之间的差异
妇女,少数民族和糖尿病患者等子人群。接下来,我们将确定提供商网络
医疗保险数据中慢性稳定心绞痛的护理,并探索提供商网络结构是否
影响提供的护理成本或内容(是否与循证实践一致)。我们将
探索网络结构在各个地理上是否有所不同,以及这是否部分解释了差异
实际上,区域之间的变化和成本。我们将确定我们的发现可能被整合到
卫生改革政策要么优化我们确定为低成本但有效护理的决定因素的因素,要么
鼓励有效的提供商网络形成。最后,我们将估计基于医疗保险的潜在储蓄
根据这些政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jay Bhattacharya其他文献
Jay Bhattacharya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jay Bhattacharya', 18)}}的其他基金
Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
- 批准号:
10216940 - 财政年份:2020
- 资助金额:
$ 19.75万 - 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
- 批准号:
10417199 - 财政年份:2020
- 资助金额:
$ 19.75万 - 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer's Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
- 批准号:
10657362 - 财政年份:2020
- 资助金额:
$ 19.75万 - 项目类别:
EXPANDING MHAS RESEARCH INFRASTRUCTURE WITH HISTORICAL CLIMATE AND LIFETIME WORKPLACE ENVIRONMENTAL EXPOSURES INFLUENCING INEQUITIES IN AD/ADRD
扩大 MHAS 研究基础设施,考虑影响 AD/ADRD 不平等的历史气候和终生工作场所环境暴露
- 批准号:
10654387 - 财政年份:2020
- 资助金额:
$ 19.75万 - 项目类别:
Exploring Medicare Provider Networks: Implications for Adoption of CER Findings
探索医疗保险提供者网络:采用 CER 研究结果的影响
- 批准号:
8212742 - 财政年份:2011
- 资助金额:
$ 19.75万 - 项目类别:
Health Insurance Provision for Vulnerable Populations
为弱势群体提供健康保险
- 批准号:
7035187 - 财政年份:2006
- 资助金额:
$ 19.75万 - 项目类别:
Health Insurance Provision for Vulnerable Populations
为弱势群体提供健康保险
- 批准号:
7234326 - 财政年份:2006
- 资助金额:
$ 19.75万 - 项目类别:
Health Insurance Provision for Vulnerable Populations
为弱势群体提供健康保险
- 批准号:
7846826 - 财政年份:2006
- 资助金额:
$ 19.75万 - 项目类别:
相似国自然基金
采用积分投影模型解析克隆生长对加拿大一枝黄花种群动态的影响
- 批准号:32301322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
山丘区农户生计分化对水保措施采用的影响及其调控对策
- 批准号:42377321
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
跨期决策中偏好反转的影响因素及作用机制:采用体验式实验范式的综合研究
- 批准号:72271190
- 批准年份:2022
- 资助金额:43 万元
- 项目类别:面上项目
农民合作社视角下组织支持、个人规范对农户化肥农药减量增效技术采用行为的影响机制研究
- 批准号:72103054
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用磁共振技术研究帕金森病蓝斑和黑质神经退变及其对大脑结构功能的影响
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Development of a novel visualization, labeling, communication and tracking engine for human anatomy.
开发一种新颖的人体解剖学可视化、标签、通信和跟踪引擎。
- 批准号:
10761060 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
mHealth OAE: Towards Universal Newborn Hearing Screening in Kenya (mTUNE)
mHealth OAE:迈向肯尼亚全民新生儿听力筛查 (mTUNE)
- 批准号:
10738905 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer
传播和实施 DIGEST™ 作为癌症吞咽困难的循证测量工具
- 批准号:
10584824 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别: